Navigation Links
Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008
Date:11/6/2008

Company Reports Seventeenth Consecutive Quarter Of Growth In Revenues

CARLSBAD, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today reported revenues of $32.1 million for the third quarter of 2008, which includes a $2.5 million benefit from changes in accounting estimates relating to prior periods. This compares to revenues of $16.2 million for the same period in 2007, including $612 thousand from changes in prior period estimates. For the first nine months of 2008, revenues were $82.2 million, up from $40.8 million for the respective period in 2007.

"We are proud of our continuing success as we delivered another quarter of robust performance, achieving increases of 98% in revenues over the third quarter of 2007 and 102% over the first nine months of last year," said Tina S. Nova, Ph.D., President and CEO of Genoptix. "This growth is driven by our commitment to providing high quality diagnostic services to a greater number of customers nationwide. Our expanded sales efforts have once again resulted in our diagnosing a greater number of cases, which increased to nearly 9,900 since the beginning of July, our seventeenth consecutive quarter of solid growth in revenues and the number of patients served."

The Company also reported GAAP net income of $15.4 million for the third quarter ended September 30, 2008 and $26.0 million for the first nine months of 2008, compared to GAAP net income of $3.6 million and $8.7 million for the three and nine months ended September 30, 2007. Diluted earnings per share, or EPS, for the third quarter of 2008 was $0.87 based on 17.8 million weighted average common shares outstanding, including a $0.35 net benefit resulting
'/>"/>

SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Genoptix, Inc. Announces Pricing for Initial Public Offering
2. Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
3. Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
4. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
5. Genoptix Announces Pricing of Secondary Public Offering
6. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
7. Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
8. Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record
9. Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference
10. Genoptix Reports Strong Financial Results for First Quarter 2008
11. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... Benaroya Research Institute at Virginia Mason (BRI) recently received ... in metastatic breast cancer reduces both the growth of ... scientists have found in models of the disease that ... 80 percent and can keep the tumor from metastasizing ... grant comes from the National Cancer Institute of the ...
(Date:4/18/2014)... Northwestern Medicine scientists could lead to potential new treatments ... with scleroderma. , Fibrosis, or scarring, is a ... skin and lungs can lead to serious organ damage ... new therapeutic options centers on findings made by Swati ... the role that a specific protein plays in promoting ...
(Date:4/17/2014)... targets that could be used to provide relief ... London made the discovery when researching how pain ... body. , Dr Marzia Malcangio said: "We have ... and our findings could help chemotherapy patients who ... side effect of some chemotherapy drugs (such as ...
(Date:4/17/2014)... San Diego School of Medicine report that older women, ... major loss are more likely to be compassionate toward ... published in this month,s issue of the International ... are associated with better health and well-being as we ... improve the outcomes of individuals whose deficits in compassion ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2
... Glan Clywd Hospital will soon offer local cancer patients ... radiotherapy technology on two new treatment machines from Varian ... the Clinac(R) linear accelerators with RapidArc are installed, the ... to offer this new, faster form of radiotherapy that ...
... (NYSE: DHR ) announced today that ... quarterly dividend of $0.03 per share payable on ... June 26, 2009.Danaher Corporation is a leading manufacturer ... Tools and Components ( www.danaher.com ). ...
... Outpatient, Inpatient SettingsBOSTON, May 7 MedAptus(R), market ... the distinguished Lenox Hill Interventional Cardiac & Vascular ... to implement Professional Intelligent Charge Capture. Nearly ... of the most highly respected cardiovascular care programs ...
... Ohio, May 7 STERIS Corporation (NYSE: STE ... a 38% increase in its quarterly dividend to $0.11 per ... to shareholders of record at the close of business on ... of STERIS Corporation is to provide a healthier today and ...
... EPS Guidance , WARSAW, Ind., May 7 First Quarter 2009 Highlights: ... Revenue of $101.4 million, comparable year-over-year and up 6.8% on a constant currency ... 24.2%, up 70 basis points year-over-year and up 80 basis points over the ... Operating income of $11.2 million, up 17.2% year-over-year and up 18.2% over the ...
... a.m. EDT at www.isispharm.com CARLSBAD, Calif., May 7 ... announced its financial results for the quarter ended March 31, ... gain that Isis recognized from selling its Ibis Biosciences subsidiary ... of 2009 with pro forma net income of $173.0 million. ...
Cached Medicine News:Health News:Cancer Patients in North Wales to Gain Access to Varian's RapidArc Radiotherapy Treatments 2Health News:MedAptus' Charge Capture Technology Deployed at Leading Manhattan Cardiovascular Practice 2Health News:MedAptus' Charge Capture Technology Deployed at Leading Manhattan Cardiovascular Practice 3Health News:STERIS Corporation Announces Quarterly Dividend Increase of 38% 2Health News:STERIS Corporation Announces Quarterly Dividend Increase of 38% 3Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 2Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 3Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 4Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 5Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 6Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 7Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 8Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 2Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 3Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 4Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 5Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 6Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 7Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 8Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 9Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 10Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 11Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 12Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 13Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 14Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 15Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 16Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 17Health News:Isis Reports Strong Financial Results and Highlights for First Quarter of 2009 18
(Date:1/15/2014)... 2014 AARP Foundation today announced it has established a ... the severe cold weather that has gripped much of the ... in need; so to support these emergency relief efforts AARP ... which could mean up to $500,000 in aid. The matching ...
(Date:1/15/2014)... 15, 2014 Massachusetts General Hospital (MGH), the ... ) announced today that they have launched a ... therapeutic targets and develop novel therapies for inflammatory ... millions worldwide. The MGH-Broad-Amgen collaboration brings together scientists ...
(Date:1/15/2014)... NEW YORK , January 15, 2014 ... BreedIT Ltd., the exclusive worldwide distributor of highly sophisticated ... that on January 7, 2014, the Company,s board of ... Ben-Zion Weiner as its new member of the ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... Four 62 mirrors ... the angle with little ... flange is convenient for ... fissures. Anterior holding ring ...
Small size gonio lens with one 62 mirror. Compact knurled ring simplifies 360 viewing of the anterior chamber angle....
Mcintyre straight lachrymal cannula, closed end, two side ports at 0.3 mm, straight shaft....
McIntyre lacrimal cannula, dual 0.3 mm side ports, straight....
Medicine Products: